Abstract:Cancer immunotherapy is rapidly becoming one of the pillars of anti-cancer therapy. Unlike previous cancer therapies, immunotherapy aims at activating or enhancing the natural immune response of the patient to kill cancer cells and tissues. It means that the immune system can be activated to attack the cancer cells but leaving the normal, healthy cells intact. Immunotherapy can be realised in several treatment approaches, such as the increase of the non-specific immune system, by cancer vaccines, adoptive cell transfer and monoclonal antibodies. Considering the heterogenicity and genetic instability of tumors, a certain kind of treatment may not achieve ideal therapeutic effect all the time. In recent years, using ultrasound to achieve immune response towards cancer shows great promise. Ultrasound is one of the most commonly used imaging diagnostic techniques for cancer diseases. Besides, ultrasound has attraction for both direct US treatment and activating drug delivery due to its biological effects. Several studies suggest that ultrasound can be used to boost the host anti-tumor immune responses. The recent advances, the potential and existing problems of US induced cancer immunotherapy are reviewed. Focused ultrasound (FUS) can achieve a high US energy with in a small focal volume, which causes local destruction of tumor tissues with minimal damage to surrounding normal tissues. Destruction of tumors caused by FUS may lead to generate tumor debris and tumor-associated antigens (TAAs) in situ , which can facilitate and amplify the anti-tumor immune responses, and protect the body from tumorgenesis when re-challenged. HIFU also has effects on other than the destruction of the tissue. HIFU treatment, which triggers a Th1 type response, leads to significant changes in cell-mediated immunity. HIFU treatment also acts by balancing the cancer-induced immuno-suppression in tumor micro-environment. Microbubbles (MBs), a kind of US contrast agents, can improve the therapeutic efficacy of FUS because of their intensity reflection and scattering of ultrasonic waves, which shows great value in clinical use. The addition of MBs to FUS can help generate more local destruction in the area of focus. Combination FUS with microbubbles has been found to increase the permeability of the blood-brain barrier (BBB) and provide a temporary and targeted opening of the BBB without inflicting brain damage or inflammation, thus is an attractive means to deliver immune cells and drugs. Sonoporation is the use of sound (typically ultrasonic frequencies) for modifying the permeability of the cell plasma membrane. Sonoporation employs the acoustic cavitation of microbubbles to enhance delivery of large molecules. This technique is usually used in gene therapy and drug delivery. Another way to achieve anti-tumor immune responses is using US and MBs to deliver immune-stimulating substances to immune cells or tumor cells. Drug delivery that using a combination of MBs and US has been explored. Non-destructive US with or without MBs can increase the delivery of active substances including antigens and immune-stimulating genes. Combination of microbubbles with cell-targeting ligands and US provides an even more smart delivery system, therefore, the therapy is not only site specific but also cell specific. Overall, the use of US to achieve immune response towards cancer is showing promise. The field is fairly young and many mechanisms are still not fully understood, thus further researches are needed.

Low-frequency ultrasound-mediated cytokine transfection enhances T cell recruitment at local and distant tumor sites

Ultrasound Improved Immune Adjuvant Delivery to Induce DC Maturation and T Cell Activation.

Translational Prospects of Ultrasound-Mediated Tumor Immunotherapy: A Review of Preclinical Advances and Safety Considerations.

Local delivery of cell surface-targeted immunocytokines programs systemic antitumor immunity

Local delivery of cell surface-targeted immunocytokines programs systemic anti-tumor immunity

Synergies Between Therapeutic Ultrasound, Gene Therapy and Immunotherapy in Cancer Treatment.

Optimization of Microbubble‐Based DNA Vaccination with Low‐Frequency Ultrasound for Enhanced Cancer Immunotherapy

Ultrasound -Induced Thermal Effect Enhances the Efficacy of Chemotherapy and Immunotherapy in Tumor Treatment

Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models

Advances of ultrasound in tumor immunotherapy

Low-intensity focused ultrasound targeted microbubble destruction reduces tumor blood supply and sensitizes anti-PD-L1 immunotherapy

Local administration of mRNA encoding cytokine cocktail confers potent anti-tumor immunity

Combination of thermal ablation by focused ultrasound, pFAR4-IL-12 transfection and lipidic adjuvant provide a distal immune response

T-lymphocytes from focused ultrasound ablation subsequently mediate cellular antitumor immunity after adoptive cell transfer immunotherapy

Ultrasound Induced Cancer Immunotherapy

Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity

Non-viral-mediated gene transfer of OX40 ligand for tumor immunotherapy

Tumor Priming by Ultrasound Mechanogenetics for with SynNotch CAR T Therapy

Augmenting Tumor Lysis and Immune Response through HIFU-armed Oncolytic Virus Delivery System

Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade

Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors